Suchergebnisse - "Hayden, Frederick G"

PubPharm (82)

1

Favipiravir Treatment of Uncomplicated Influenza in Adults : Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials

enthalten in: The Journal of infectious diseases | 2022

von Hayden, F. | Lenk, R. | Stonis, L. | +3

2

Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels

enthalten in: Scientific reports | 2022

von Arabi, Y. | Asiri, A. | Assiri, A. | +21

3

Reducing Influenza Virus Transmission : The Potential Value of Antiviral Treatment

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Hayden, F. | Asher, J. | Cowling, B. | +10

4

Influenza polymerase inhibitor resistance : Assessment of the current state of the art - A report of the isirv Antiviral group

enthalten in: Antiviral research | 2021

von Ison, M. | Hayden, F. | Hay, A. | +4

5

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

enthalten in: The Journal of infectious diseases | 2021

von Hall, M. | Anderson, J. | Anderson, A. | +39

6

Baloxavir Treatment in Adolescents With Acute Influenza : Subgroup Analysis From the CAPSTONE-1 Trial

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2021

von Portsmouth, S. | Hayden, F. | Kawaguchi, K. | +5

7

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances

enthalten in: Cold Spring Harbor perspectives in medicine | 2021

von Beigel, J. | Hayden, F.

8

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough

enthalten in: Lancet (London, England) | 2020

von Cao, B. | Hayden, F.

CommentOn: Lancet. 2020 Oct 24;396(10259):1345-1352. - PMID 33031764

9

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2) : a randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2020

von Ison, M. | Portsmouth, S. | Yoshida, Y. | +5

CommentIn: Lancet Infect Dis. 2020 Oct;20(10):1112-1114. - PMID 32526194

10

Respiratory Syncytial Virus Antivirals : Problems and Progress

enthalten in: The Journal of infectious diseases | 2020

von Hayden, F. | Whitley, R.

CommentOn: J Infect Dis. 2020 Oct 1;222(9):1468-1477. - PMID 31971597

1
2
3
4
5
6
7
8
9
Nächster »
[9]